비피도
238200KOSDAQ기타 식품 제조업45.1 / 100
Reference Date: 2026-06-10
Company InformationBased on 2025 Annual Report
Business Overview
Bifido is a company that produces probiotic raw materials and finished products based on physiologically active bifidobacteria strains discovered by Professor Ji Geun-eok in 1994. It holds FDA NDI and GRAS certifications and utilizes the MAP platform technology to develop functional probiotics and microbiome-based therapeutics. The company is also expanding into B2C markets through the development of individually recognized probiotic raw materials.
Number of Employees
102people
Average Salary
42.5M KRW
Score Calculation Basis
Detailed Financial Score
Lower than industry avg (good)
Well below industry avg
Half of industry avg (excellent)
Avg ▲12.8% (2-year basis)
Avg ▼537.9% (2-year basis)
Avg ROE -3.1% (declining, 3yr)
Detailed News Sentiment
- Neutral김석진 헥토헬스케어 대표, JTBC 다큐 출연…"프로바이오틱스, 균형·...
김석진 헥토헬스케어 대표의 프로바이오틱스 관련 다큐멘터리 출연은 회사 이미지 제고에 도움이 될 수 있으나, 직접적인 재무 영향은 제한적입니다.
- NeutralJTBC 다큐가 조명한 ‘두 번째 뇌’ 장…드시모네, 유산균 고르는 ...
JTBC 다큐멘터리가 장과 뇌의 상호작용을 다루었으나, 직접적인 비피도 주식 영향은 미미함.
Detailed Momentum
Near 52w low (0%, downtrend)
1m -20.89% (strong drop)
Volume decreasing
Detailed Disclosure
- Neutral[기재정정]주요사항보고서(유형자산양도결정)2026-05-19
- Neutral분기보고서 (2026.03)2026-05-15
